Esophageal Cancer,Gastrointestinal Cancer Durvalumab and FLOT in Resectable GC/GEJC: MATTERHORN Jan 19, 2024
Esophageal Cancer,Gastric Cancer,Gastrointestinal Cancer CtDNA Profiling and Kinetics in Gastroesophageal Cancer Treated With Pembrolizumab Oct 20, 2023
Breast Cancer,Esophageal Cancer,Gastric Cancer,Gastrointestinal Cancer,HER2- Phase 1 Study of BLU-222 in Advanced Solid Tumors Sep 26, 2023
Esophageal Cancer,Gastric Cancer,Gastrointestinal Cancer BLU-222 Phase 1 Monotherapy Dose Escalation in Solid Tumors Sep 26, 2023
Esophageal Cancer,Gastrointestinal Cancer Pembrolizumab Plus Trastuzumab and Chemotherapy for HER2+ Metastatic G/GEJ cancer Aug 03, 2023
Esophageal Cancer,Gastrointestinal Cancer Analyzing Resected Esophageal or Gastroesophageal Junction Cancer in Adjuvant Nivolumab Aug 03, 2023
Esophageal Cancer,Gastrointestinal Cancer Tislelizumab + Chemo vs. Placebo + Chemo as 1L Treatment for Advanced Esophageal Cancer May 02, 2023
Esophageal Cancer,Gastrointestinal Cancer A Cost-Effectiveness Analysis on Pembrolizumab +Chemo vs. Chemo Alone for Advanced Esophageal Cancer Apr 28, 2023
